Increasing Prevalence of Cardiovascular Diseases and Obesity and Increasing Number of Geriatric People are expected to drive the Global LDL Test Market in the forecast period of 2019 to 2026


DRIVERS:

Increasing Prevalence of Cardiovascular Diseases and Obesity

Increasing Number of Geriatric People

Access Full Report at https://databridgemarketresearch.com/reports/global-ldl-test-market/

RESTRAINT:

Risks Associated with Tests such as Bleeding and Infection

OPPORTUNITY:

Patient-Initiated Testing

CHALLENGE:

Patient Data Security

Market Trends:

Global LDL test market is segmented into four notable segments such as components, disease, distribution channel, end user.

  • On the basis of component, the market is segmented into devices, kits & reagents and services.
  • On the basis of disease, the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others. In 2019, diabetes segment is projected to dominate the market.
  • On the basis of distribution channel, the market is segmented into direct tender and retail.
  • On the basis of end user, the market is segmented into hospitals, clinics, ambulatory care, and research laboratory. In 2019, hospital segment is projected to grow with the highest CAGR in the forecast period of 2019 to 2026.

Major Players: Global LDL Test Market

Some of the major players operating in this market are Quest Diagnostics, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckondiagnostics, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Abbott, Eurolyser Diagnostica GmbH, Sigma-Aldrich, Diazyme Laboratories, Inc, Laboratory Corporation of America, Cell Biolabs, Inc, Atlas Medical U.K, Eurofins Scientific, Thermo Fisher Scientific Inc, Home Access Health and Others.


Choose License Type
  • 200
  • 300
BUY NOW ADD TO CART